Advanced company searchLink opens in new window

CENTESSA PHARMACEUTICALS (UK) LIMITED

Company number 13040752

Filter by category

Filter by category


Confirmation statement filters

Company Results (links open in a new window)
Date (document was filed at Companies House) Type Description (of the document filed at Companies House) View / Download (PDF file, link opens in new window)
26 Apr 2021 PSC05 Change of details for United Medicines Biopharma Limited as a person with significant control on 17 February 2021
23 Apr 2021 AA01 Current accounting period extended from 30 November 2021 to 31 December 2021
20 Apr 2021 TM02 Termination of appointment of Nicholas Alexander James Tait as a secretary on 20 April 2021
22 Feb 2021 TM01 Termination of appointment of Richard Michael Lee as a director on 19 February 2021
22 Feb 2021 AP01 Appointment of Ms Marella Thorell as a director on 19 February 2021
  • ANNOTATION Clarification a second filed AP01 was registered on 25/11/2021
22 Feb 2021 AP01 Appointment of Mr Iqbal Hussain as a director on 19 February 2021
22 Feb 2021 AP01 Appointment of Dr Saurabh Saha as a director on 19 February 2021
22 Feb 2021 TM01 Termination of appointment of Francesco De Rubertis as a director on 19 February 2021
17 Feb 2021 RESOLUTIONS Resolutions
  • NM01 ‐ Change of name by resolution
  • RES15 ‐ Change company name resolution on 2021-02-14
11 Dec 2020 AP03 Appointment of Mr Nicholas Alexander James Tait as a secretary on 24 November 2020
07 Dec 2020 AP01 Appointment of Mr Francesco De Rubertis as a director on 4 December 2020
24 Nov 2020 NEWINC Incorporation
  • MODEL ARTICLES ‐ Model articles adopted

Statement of capital on 2020-11-24
  • GBP 1